Biotech Values

[DewDiligence]

INVO reverse-merges with—(private)—NAYA Biosciences:

https://www.prnewswire.com/news-releases/invo-bioscience-and-naya-biosciences-announce-definitive-merger-agreement-to-establish-expanded-publicly-traded-life-science-company-301964066.html

Subject to the Interim PIPE, post-transaction and prior to the private offering, INVO and NAYA shareholders will own approximately 12% and 88%, respectively, of the combined company.

…NAYA Biosciences is building a group of agile, disruptive, high-growth companies dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative medicine.

A rather broad mission statement, LOL.